Comparison of drug Dexmedetomidine and Fentanyl as an adjuvant to Ropivacaine in epidural space for post operative pain relief in abdominal hysterectomy patients.

COMPARISON OF DEXMEDETOMIDINE AND FENTANYL AS AN ADJUVANT TO ROPIVACAINE FOR EPIDURAL ANALGESIA IN ABDOMINAL HYSTERECTOMY REGARDING QUALITY OF POSTOPERATIVE ANALGESIA.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/01/039726

Enrollment

Registered

2022-01-25

Start date

Unknown

Completion date

Unknown

Last updated

2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Ropivacaine: Ropivacaine+ Dexmedetomidine in epidural analgesia Intervention2: Dexmedetomidine: Group RD: Ropivacaine (0.125 %) +1Âµg/ml Dexmedetomidine @7ml/hr for 24 hours. Control In

Eligibility

Inclusion criteria

Inclusion criteria: All patients with ASA status type I, II aged between 30-60 who will be undergoing abdominal hysterectomy surgeries.

Exclusion criteria

Exclusion criteria: a) All patients who are not willing to consent, b) All patients who have a history of allergies to any of the drugs used in the study, c) Bleeding diathesis, uncontrolled hypertension and heart rate.

Design outcomes

Primary

Measure	Time frame
The degree of motor block will be assessed by the Modified Bromage scaleTimepoint: 1 hr-24hrs	—

Secondary

Measure	Time frame
Post-operative pain scores will be recorded using visual analogue scale (VAS) ranging from 0 to 10Timepoint: 1 hr -24hrs	—

Countries

India

Contacts

Public ContactPuja Kumari

Rajendra Institute of Medical Sciences, Ranchi

drkmukesh@gmail.com9955360544

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026